Targeted therapy in her2-positive metastatic breast cancer: a review of the literature.
about
A novel immunotherapy targeting MMP-14 limits hypoxia, immune suppression and metastasis in triple-negative breast cancer models.Selective expression of constitutively active pro-apoptotic protein BikDD gene in primary mammary tumors inhibits tumor growth and reduces tumor initiating cells.A novel double-negative feedback loop between miR-489 and the HER2-SHP2-MAPK signaling axis regulates breast cancer cell proliferation and tumor growthIdentification of breast cancer cell subtypes sensitive to ATG4B inhibition.Role of everolimus in the treatment of metastatic HER2-negative/HR-positive breast cancer.Pathologic Complete Response with Neoadjuvant Doxorubicin and Cyclophosphamide Followed by Paclitaxel with Trastuzumab and Pertuzumab in Patients with HER2-Positive Early Stage Breast Cancer: A Single Center Experience.Engineered T cells: the promise and challenges of cancer immunotherapy.Precision Oncology Medicine: The Clinical Relevance of Patient-Specific Biomarkers Used to Optimize Cancer Treatment.Breast cancer subtype and stage are prognostic of time from breast cancer diagnosis to brain metastasis development.Genetic heterogeneity and actionable mutations in HER2-positive primary breast cancers and their brain metastases.HER2 inhibition in gastro-oesophageal cancer: A review drawing on lessons learned from breast cancer
P2860
Q36379157-9FA1BABA-635C-4452-8621-0ACB704D77FCQ36516589-A6108532-9A89-4601-8525-1A48DB22CDC1Q37109741-6EFF4675-27ED-42DB-9CA8-F2A5E8A72098Q37687104-818BCF52-4A9B-47B8-9D06-ED265BA3756CQ38690803-AE5AAFC0-D5C3-4B8F-8CAF-C890A5EE9954Q38760664-9FA26C19-60C0-4A1C-BD8D-9A449FE3E30EQ38828829-EFEE7CC1-C8C5-4EE0-9710-F69B79ACFC68Q38838757-B1E7363D-43A4-47DB-B1D0-3A4A17055C8AQ48213140-A184A5B2-AE84-4E8E-82D1-E8BC7F64ECAAQ55394663-7AE91AAB-FA01-423A-8342-BB8B9CAD5A64Q57109545-B123C29D-E460-48D2-AAB2-9D863BCCCA77
P2860
Targeted therapy in her2-positive metastatic breast cancer: a review of the literature.
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Targeted therapy in her2-positive metastatic breast cancer: a review of the literature.
@ast
Targeted therapy in her2-positive metastatic breast cancer: a review of the literature.
@en
type
label
Targeted therapy in her2-positive metastatic breast cancer: a review of the literature.
@ast
Targeted therapy in her2-positive metastatic breast cancer: a review of the literature.
@en
prefLabel
Targeted therapy in her2-positive metastatic breast cancer: a review of the literature.
@ast
Targeted therapy in her2-positive metastatic breast cancer: a review of the literature.
@en
P2860
P356
P1433
P1476
Targeted therapy in her2-positive metastatic breast cancer: a review of the literature.
@en
P2860
P304
P356
10.3747/CO.22.2363
P433
P577
2015-03-01T00:00:00Z